Short answer
Editas Medicine, Inc. (EDIT) filed an 8-K current report with the SEC on May 26, 2026 reporting Item 8.01 (Other Events). ATM prospectus supplement suspended and terminated effective May 26, 2026.
Editas Medicine, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- ATM prospectus supplement suspended and terminated effective May 26, 2026
- No additional shares saleable until new prospectus or registration becomes effective
- 14,327,365 shares sold through ATM program for $43.9 million gross proceeds
- Sales Agreement remains active, preserving future equity-financing access after updated SEC filings
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Editas Medicine, Inc. 8-K filings
Get the next EDIT 8-K as it lands
Follow EDIT for push alerts, or ask the research agent what this filing means.